Skip to content
Thursday, February 05, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Canadian Jewish groups decry axing of antisemitism envoy in favor of ‘rights, equality and inclusion’ advisory council February 5, 2026
  • Most US Jews do not identify as ‘Zionists,’ even when they support Israel, JFNA survey finds February 5, 2026
  • The Wolfs Open Chabad in Fairbanks February 5, 2026
  • Palestine Action activists acquitted in Israeli defense firm break-in, drawing criticism from British Jewish leaders February 4, 2026
  • In moments of crisis, Jewish National Fund-USA is there February 4, 2026
  • My Adventure Of A Lifetime February 4, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.